SS Innovations International (NASDAQ:SSII – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.03) earnings per share for the quarter, Zacks reports. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The business had revenue of $6.33 million during the quarter.
SS Innovations International Stock Up 3.0%
NASDAQ:SSII traded up $0.04 during midday trading on Wednesday, hitting $1.37. The company had a trading volume of 27,122 shares, compared to its average volume of 75,907. The company has a market capitalization of $274.52 million, a PE ratio of -22.83 and a beta of -1.52. SS Innovations International has a 52-week low of $1.12 and a 52-week high of $6.79. The stock’s fifty day moving average price is $2.56 and its 200-day moving average price is $3.69.
Insiders Place Their Bets
In other SS Innovations International news, CEO Srivastava Sudhir sold 33,333 shares of SS Innovations International stock in a transaction dated Friday, September 4th. The stock was sold at an average price of $3.00, for a total transaction of $99,999.00. Following the completion of the sale, the chief executive officer owned 108,520,928 shares of the company’s stock, valued at $325,562,784. The trade was a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.
Wall Street Analysts Forecast Growth
Get Our Latest Research Report on SS Innovations International
SS Innovations International Company Profile
SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.
See Also
- Five stocks we like better than SS Innovations International
- General Motors Faces a Cost Squeeze as Factory Automation Takes Center Stage
- 5 Consumer Discretionary Plays Showing Strength During the Tech Sell-Off
- NVIDIA’s Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?
- SpaceX’s Historic Starship Catch Raises a Bigger Question About Its AI Spending
Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.
